Macquarie Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.9M | Sell |
37,980
-2,256
| -6% | -$1,000K | 0.08% | 194 |
|
|
2026
Q1 | $18M | Sell |
40,236
-4,500
| -10% | -$2.1M | 0.11% | 167 |
|
|
2025
Q4 | $20.3M | Sell |
44,736
-178,820
| -80% | -$77.1M | 0.09% | 179 |
|
|
2025
Q3 | $87.6M | Sell |
223,556
-5,297
| -2% | -$2.21M | 0.1% | 264 |
|
|
2025
Q2 | $102M | Sell |
228,853
-5,283
| -2% | -$2.43M | 0.13% | 226 |
|
|
2025
Q1 | $114M | Buy |
234,136
+4,203
| +2% | +$1.96M | 0.14% | 202 |
|
|
2024
Q4 | $88.7M | Sell |
229,933
-96,583
| -30% | -$44.8M | 0.11% | 265 |
|
|
2024
Q3 | $152M | Sell |
326,516
-9,229
| -3% | -$4.43M | 0.16% | 161 |
|
|
2024
Q2 | $157M | Sell |
335,745
-36,496
| -10% | -$15.8M | 0.18% | 143 |
|
|
2024
Q1 | $156M | Sell |
372,241
-25,053
| -6% | -$10.6M | 0.18% | 151 |
|
|
2023
Q4 | $162M | Sell |
397,294
-333,639
| -46% | -$123M | 0.19% | 137 |
|
|
2023
Q3 | $254M | Buy |
730,933
+16,498
| +2% | +$5.77M | 0.32% | 57 |
|
|
2023
Q2 | $251M | Sell |
714,435
-51,939
| -7% | -$17.5M | 0.29% | 61 |
|
|
2023
Q1 | $241M | Sell |
766,374
-92,926
| -11% | -$27.9M | 0.29% | 65 |
|
|
2022
Q4 | $248M | Sell |
859,300
-38,008
| -4% | -$11.6M | 0.29% | 60 |
|
|
2022
Q3 | $260M | Sell |
897,308
-35,871
| -4% | -$10.3M | 0.32% | 59 |
|
|
2022
Q2 | $263M | Buy |
933,179
+652,321
| +232% | +$175M | 0.3% | 64 |
|
|
2022
Q1 | $73.3K | Sell |
280,858
-23,399
| -8% | -$5.55M | 0.06% | 396 |
|
|
2021
Q4 | $66.8M | Sell |
304,257
-1,046,258
| -77% | -$203M | 0.06% | 427 |
|
|
2021
Q3 | $245M | Sell |
1,350,515
-266,259
| -16% | -$52M | 0.21% | 100 |
|
|
2021
Q2 | $326M | Buy |
1,616,774
+1,466,287
| +974% | +$307M | 0.27% | 79 |
|
|
2021
Q1 | $32.3M | Buy |
150,487
+14,384
| +11% | +$3.16M | 0.05% | 430 |
|
|
2020
Q4 | $32.2M | Buy |
136,103
+5,739
| +4% | +$1.32M | 0.05% | 402 |
|
|
2020
Q3 | $35.5M | Buy |
130,364
+19,437
| +18% | +$5.36M | 0.06% | 339 |
|
|
2020
Q2 | $32.2M | Buy |
110,927
+1,807
| +2% | +$490K | 0.06% | 357 |
|
|
2020
Q1 | $26M | Sell |
109,120
-15,009
| -12% | -$3.44M | 0.05% | 356 |
|
|
2019
Q4 | $27.2M | Sell |
124,129
-15,512
| -11% | -$3.14M | 0.04% | 428 |
|
|
2019
Q3 | $23.7M | Buy |
139,641
+3,050
| +2% | +$540K | 0.04% | 418 |
|
|
2019
Q2 | $25M | Sell |
136,591
-19,219
| -12% | -$3.36M | 0.04% | 407 |
|
|
2019
Q1 | $28.7M | Sell |
155,810
-3,540
| -2% | -$654K | 0.05% | 385 |
|
|
2018
Q4 | $26.4M | Buy |
159,350
+5,713
| +4% | +$990K | 0.05% | 364 |
|
|
2018
Q3 | $29.6M | Sell |
153,637
-13,490
| -8% | -$2.4M | 0.05% | 387 |
|
|
2018
Q2 | $28.4M | Sell |
167,127
-13,605
| -8% | -$2.11M | 0.05% | 403 |
|
|
2018
Q1 | $29.5M | Buy |
180,732
+12,459
| +7% | +$2.04M | 0.05% | 371 |
|
|
2017
Q4 | $24.9M | Sell |
168,273
-56,001
| -25% | -$8.29M | 0.04% | 423 |
|
|
2017
Q3 | $34.1M | Buy |
224,274
+16,927
| +8% | +$2.55M | 0.06% | 323 |
|
|
2017
Q2 | $26.7M | Sell |
207,347
-3,048
| -1% | -$367K | 0.05% | 378 |
|
|
2017
Q1 | $23M | Sell |
210,395
-25,252
| -11% | -$2.22M | 0.04% | 422 |
|
|
2016
Q4 | $17.4M | Sell |
235,647
-28,449
| -11% | -$2.31M | 0.03% | 476 |
|
|
2016
Q3 | $23M | Sell |
264,096
-263,536
| -50% | -$24.9M | 0.04% | 367 |
|
|
2016
Q2 | $45.4M | Buy |
527,632
+239,951
| +83% | +$20.7M | 0.04% | 339 |
|
|
2016
Q1 | $22.9M | Buy |
287,681
+38,051
| +15% | +$3.44M | 0.05% | 312 |
|
|
2015
Q4 | $31.4M | Buy |
249,630
+8,940
| +4% | +$1.08M | 0.06% | 258 |
|
|
2015
Q3 | $25.1M | Buy |
240,690
+78,650
| +49% | +$10.1M | 0.05% | 295 |
|
|
2015
Q2 | $20M | Sell |
162,040
-64,317
| -28% | -$8.1M | 0.04% | 363 |
|
|
2015
Q1 | $26.7M | Buy |
226,357
+6,347
| +3% | +$760K | 0.05% | 328 |
|
|
2014
Q4 | $26.1M | Sell |
220,010
-11,195
| -5% | -$1.26M | 0.05% | 332 |
|
|
2014
Q3 | $26M | Sell |
231,205
-18,334
| -7% | -$1.75M | 0.06% | 321 |
|
|
2014
Q2 | $23.6M | Sell |
249,539
-110,020
| -31% | -$7.71M | 0.05% | 328 |
|
|
2014
Q1 | $25.4M | Buy |
359,559
+35,110
| +11% | +$2.78M | 0.04% | 300 |
|
|
2013
Q4 | $24.1M | Sell |
324,449
-1,320
| -0.4% | -$91.9K | 0.04% | 297 |
|
|
2013
Q3 | $24.7M | Buy |
325,769
+2,400
| +0.7% | +$191K | 0.05% | 286 |
|
|
2013
Q2 | $25.8M | Buy |
+323,369
| New | +$23.8M | 0.06% | 263 |
|
Other funds holding VRTX
Macquarie Group's VRTX Position: Q2 2026 in Review
Macquarie Group reduced its Vertex Pharmaceuticals (VRTX) stake by 5.6% in Q2 2026, selling an estimated $1,000K and leaving 37,980 shares worth $18.9M. The position accounts for 0.08% of the portfolio, ranked #194.
Macquarie Group first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $326M in Q2 2021. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Macquarie Group held 37,980 shares of Vertex Pharmaceuticals worth $18.9M as of Q2 2026.
- Macquarie Group sold 2,256 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1,000K.
- Vertex Pharmaceuticals made up 0.08% of Macquarie Group's portfolio in Q2 2026, its #194 holding.
- Macquarie Group first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Macquarie Group's Vertex Pharmaceuticals position peaked at $326M in Q2 2021.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.